Cell surface modification by activated polyethylene glycol prevents allosensitization after islet transplantation

Cell Transplantation

Volumn 17, Issue 10-11, 2008, Pages 1257-1269

  Wee, Yu Mee ^a   Lim, Dong Gyun ^a   Kim, Yang Hee ^a   Kim, Jin Hee ^a   Kim, Song Cheol ^a   Yu, EunSil ^a   Park, Myung Ok ^b   Choi, Monica Young ^a   Park, Youn Hee ^a   Jang, Hyuk Jai ^a   Cho, Eun Young ^a   Cho, Myung Hwan ^c   Han, Duck Jong ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Biopolymed Inc   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

Immunohistochemistry; Islet transplantation; Polyethylene glycol; Sensitization

Indexed keywords

MACROGOL; CROSS LINKING REAGENT; CYANURIC CHLORIDE; MACROGOL DERIVATIVE; MEMBRANE ANTIGEN; STREPTOZOCIN; TRIAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; CELL SURFACE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; GRAFT SURVIVAL; HISTOLOGY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT; SENSITIZATION; SPLEEN CELL; ANIMAL; CELL CULTURE; DRUG EFFECT; EVALUATION; EXPERIMENTAL DIABETES MELLITUS; FISCHER 344 RAT; GRAFT REJECTION; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LEWIS RAT; METHODOLOGY; PANCREAS ISLET; PHYSIOLOGY; SURFACE PROPERTY; TRANSPLANTATION TOLERANCE;

RATTUS; RODENTIA;

ANIMALS; ANTIGENS, SURFACE; CELL SURVIVAL; CELLS, CULTURED; CROSS-LINKING REAGENTS; DIABETES MELLITUS, EXPERIMENTAL; GRAFT REJECTION; IMMUNOSUPPRESSION; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; POLYETHYLENE GLYCOLS; RATS; RATS, INBRED F344; RATS, INBRED LEW; STREPTOZOCIN; SURFACE PROPERTIES; TRANSPLANTATION TOLERANCE; TRIAZINES;

EID: 60549101725     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368908787236657     Document Type: Article

References (35)

1. Abdelli, S.; Ansite, J.; Roduit, R.; Borsello, T.; Matsumoto, I.; Sawada, T.; Allaman-Pillet, N.; Henry, H.; Beckmann, J. S.; Hering, B. J.; Bonny, C. Intracellular stress signaling pathways activated during human islet preparation and following acute cytokine exposure. Diabetes 53(11):2815-2823; 2004.
2. Ablamunits, V.; Baranova, F.; Mandrup-Poulsen, T.; Nerup, J. In vitro inhibition of insulin release by blood mononuclear cells from insulin-dependent diabetic and healthy subjects: Synergistic action of IL-1 and TNF. Cell Transplant. 3(1):55-60; 1994.
3. Abuchowski, A.; van Es, T.; Palczuk, N. C.; Davis, F. F. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J. Biol. Chem. 252(11):3578-3581; 1977.
4. Arita, S.; Nagai, T.; Ochiai, M.; Sakamoto, Y.; Shevlin, L. A.; Smith, C. V.; Mullen, Y. Prevention of primary nonfunction of canine islet autografts by treatment with pravastatin. Transplantation 73(1):7-12; 2002.
5. Armstrong, J. K.; Meiselman, H. J.; Fisher, T. C. Covalent binding of poly(ethylene glycol) (PEG) to the surface of red blood cells inhibits aggregation and reduces low shear blood viscosity. Am. J. Hematol. 56(l):26-28; 1997.
6. Bennet, W.; Groth, C. G.; Larsson, R.; Nilsson, B.; Korsgren, O. Isolated human islets trigger an instant blood mediated inflammatory reaction: Implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups. J. Med. Sci. 105(2): 125-133; 2000.
7. Boccu, E.; Largajolli, R.; Veronese, F. M. Coupling of monomethoxypolyethyleneglycols to proteins via active esters. Z. Naturforsch. [C] 38(l-2):94-99; 1983.
8. Chang, T. M. Therapeutic applications of polymeric artificial cells. Nat. Rev. Drug Discov. 4(3):221-235; 2005.
9. Del Guerra, S.; Lupi, R.; Dotta, F.; Marselli, L.; Lencioni, C.; Santangelo, C.; Realacci, M.; Carmellini, M.; Mosca, F.; Navalesi, R.; Marchetti, P. Effects of prolonged exposure to pancreatic glucagon on the function, antigenicity and survival of isolated human islets. Diabetes Metab. Res. Rev. 16(4):281-286; 2000.
10. de Vos, P.; Smedema, I.; van Goor, H.; Moes, H.; van Zanten, J.; Netters, S.; de Leij, L. F.; de Haan, A.; de Haan, B. J. Association between macrophage activation and function of micro-encapsulated rat islets. Diabetologia 46(5):666-673; 2003.
11. Emamaullee, J. A.; Shapiro, A. M. Factors influencing the loss of ß-cell mass in islet transplantation. Cell Transplant. 16(1): 1-8; 2007.
12. Flesch, B. K.; Bretzel, R. G.; Otto, D. A.; Emst-Schlegel, M.; Federlin, K. Pretreatment of rat pancreatic islets with MHC I-A monoclonal antibody: In-vitro and in-vivo effects on islet antigenicity. Horm. Metab. Res. 23(8):357-361; 1991.
13. Jackson, C. J.; Charlton, J. L.; Kuzminski, K.; Lang, G. M.; Sehon, A. H. Synthesis, isolation, and characterization of conjugates of ovalbumin with monomethoxypolyethylene glycol using cyanuric chloride as the coupling agent. Anal. Biochem. 165(1): 114-127; 1987.
14. Katre, N. V. Immunogenicity of recombinant IL-2 modified by covalent attachment of polyethylene glycol. J. Immunol. 144(1):209-213; 1990.
15. Kendall, Jr., W. F.; Darrabie, M. D.; El-Shewy, H. M.; Opara, E. C. Effect of alginate composition and purity on alginate microspheres. J. Microencapsul. 21(8):821-828; 2004.
16. Kim, S. C.; Han, D. J.; Kim, I. H.; Woo, K. O.; We, Y. M.; Kang, S. Y.; Back, J. H.; Kim, Y. H.; Kim, J. H.; Lim, D. G. Comparative study on biologic and immunologic characteristics of the pancreas islet cell between 24 degrees C and 37 degrees C culture in the rat. Transplant. Proc. 37(8):3472-3475; 2005.
17. Kobayashi, T.; Aomatsu, Y.; Iwata, H.; Kin, T.; Kanehiro, H.; Hisanaga, M.; Ko, S.; Nagao, M.; Nakajima, Y. Indefinite islet protection from autoimmune destruction in non-obese diabetic mice by agarose microencapsulation without immunosuppression. Transplantation 75(5):619-625; 2003.
18. Kulseng, B.; Skjak-Braek, G.; Ryan, L.; Andersson, A.; King, A.; Faxvaag, A.; Espevik, T. Transplantation of alginate microcapsules: generation of antibodies against alginates and encapsulated porcine islet-like cell clusters. Transplantation 67(7):978-984; 1999.
19. Larsen, J. L. Pancreas transplantation: Indications and consequences. Endocr. Rev. 25(6):919-946; 2004.
20. Lim, F.; Sun, A. M. Microencapsulated islets as bioartificial endocrine pancreas. Science 210(4472):908-910; 1980.
21. Miao, G.; Ostrowski, R. P.; Mace, J.; Hough, J.; Hopper, A.; Peverini, R.; Chinnock, R.; Zhang, J.; Hathout, E. Dynamic production of hypoxia-inducible factor-1alpha in early transplanted islets. Am. J. Transplant. 6(11):2636-2643; 2006.
22. Montolio, M.; Tellez, N.; Soler, J.; Montanya, E. Role of blood glucose in cytokine gene expression in early syngeneic islet transplantation. Cell Transplant. 16(5):517-525; 2007.
23. Murad, K. L.; Mahany, K. L.; Brugnara, C.; Kuypers, F. A.; Eaton, J. W.; Scott, M. D. Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol). Blood 93(6):2121-2127; 1999.
24. Panza, J. L.; Wagner, W. R.; Rilo, H. L.; Rao, R. H.; Beckman, E. J.; Russell, A. J. Treatment of rat pancreatic islets with reactive PEG. Biomaterials 21(11):1155-1164; 2000.
25. Piro, S.; Anello, M.; Di Pietro, C.; Lizzio, M. N.; Patane, G.; Rabuazzo, A. M.; Vigneri, R.; Purrello, M.; Purrello, F. Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: Possible role of oxidative stress. Metabolism 51(10):1340-1347; 2002.
26. Robertson, R. P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem. 279(41):42351-42354; 2004.
27. Scott, M. D.; Murad, K. L. Cellular camouflage: Fooling the immune system with polymers. Curr. Pharm. Des. 4(6):423-438; 1998.
28. Scott, M. D.; Murad, K. L.; Koumpouras, F.; Talbot, M.; Eaton, J. W. Chemical camouflage of antigenic determinants: Stealth erythrocytes. Proc. Natl. Acad. Sci. USA 94(14):7566-7571; 1997.
29. Serreze, D. V.; Leiter, E. H.; Shultz, L. D. Transplantation analysis of B cell destruction in (NOD × CBA)F1 mouse bone marrow chimeras. Diabetologia 33(2):84-92; 1990.
30. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343(4):230-238; 2000.
31. Tobiasch, E.; Gunther, L.; Bach, F. H. Heme oxygenase1 protects pancreatic beta cells from apoptosis caused by various stimuli. J. Investig. Med. 49(6):566-571; 2001.
32. Weinand, S.; Jahr, H.; Hering, B. J.; Federlin, K.; Bretzel, R. G. Oxygen radical production in human mononuclear blood cells is not suppressed by drugs used in clinical islet transplantation. J. Mol. Med. 77(1): 121-122; 1999.
33. White, S. A.; Nicholson, M. L.; Hering, B. J. Can islet cell transplantation treat diabetes? BMJ 321(7262):651-652; 2000.
34. Yin, D.; Ding, J. W.; Shen, J.; Ma, L.; Hara, M.; Chong, A. S. Liver ischemia contributes to early islet failure fol- lowing intraportal transplantation: Benefits of liver ischemic-preconditioning. Am. J. Transplant. 6(l):60-68; 2006.
35. Zekorn, T. D.; Horcher, A.; Siebers, U.; Federlin, K.; Bretzel, R. G. Synergistic effect of microencapsulation and immunoalteration on islet allograft survival in bioartificial pancreas. J. Mol. Med. 77(1):193-198; 1999.